James Charlesworth

404 total citations
14 papers, 231 citations indexed

About

James Charlesworth is a scholar working on Immunology, Infectious Diseases and Dermatology. According to data from OpenAlex, James Charlesworth has authored 14 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Infectious Diseases and 3 papers in Dermatology. Recurrent topics in James Charlesworth's work include Immune Cell Function and Interaction (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). James Charlesworth is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). James Charlesworth collaborates with scholars based in United Kingdom, United States and Mexico. James Charlesworth's co-authors include Nia Roberts, Jeremy Howick, Franklin G. Miller, John M. Kelley, Igho Onakpoya, Amrana Qureshi, Shaun Wilson, Dominic F. Kelly, Shelley Segal and James Weitz and has published in prestigious journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology and Archives of Disease in Childhood.

In The Last Decade

James Charlesworth

13 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Charlesworth United Kingdom 7 140 71 62 35 23 14 231
Saifuddin Kharawala United States 8 29 0.2× 77 1.1× 6 0.1× 85 2.4× 12 0.5× 13 225
Elena Brunori Italy 13 35 0.3× 67 0.9× 5 0.1× 48 1.4× 8 0.3× 22 358
Beatriz Hemo Israel 9 87 0.6× 37 0.5× 5 0.1× 7 0.2× 20 0.9× 15 350
Mogens Fjord Christensen Denmark 7 15 0.1× 119 1.7× 4 0.1× 18 0.5× 19 0.8× 15 337
Elizabeth Dawson United States 10 27 0.2× 16 0.2× 10 0.2× 6 0.2× 11 0.5× 15 306
Martine Marchand France 5 75 0.5× 194 2.7× 13 0.2× 2 0.1× 4 0.2× 9 383
Emily Hartung Canada 7 15 0.1× 228 3.2× 19 0.3× 7 0.2× 8 0.3× 16 359
Henry Ng Sweden 10 17 0.1× 42 0.6× 4 0.1× 98 2.8× 48 2.1× 15 410
Louise Warren United States 4 67 0.5× 35 0.5× 6 0.1× 33 0.9× 2 0.1× 7 208
Moshe Herskovitz Israel 9 24 0.2× 94 1.3× 3 0.0× 8 0.2× 2 0.1× 28 286

Countries citing papers authored by James Charlesworth

Since Specialization
Citations

This map shows the geographic impact of James Charlesworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Charlesworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Charlesworth more than expected).

Fields of papers citing papers by James Charlesworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Charlesworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Charlesworth. The network helps show where James Charlesworth may publish in the future.

Co-authorship network of co-authors of James Charlesworth

This figure shows the co-authorship network connecting the top 25 collaborators of James Charlesworth. A scholar is included among the top collaborators of James Charlesworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Charlesworth. James Charlesworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Russell, Neal, James Hatcher, Judith Breuer, et al.. (2025). Severe Parvovirus B19–Associated Myocarditis in Children in the Post–COVID-19 Era: A Multicenter Observational Cohort Study. Open Forum Infectious Diseases. 12(5). ofaf224–ofaf224. 1 indexed citations
2.
Charlesworth, James. (2024). Mind the (preterm) gap: inequality in the UK’s current RSV immunisation approach will leave many preterm babies unprotected against RSV this winter. Archives of Disease in Childhood. 110(8). 662–664. 1 indexed citations
3.
Charlesworth, James, et al.. (2024). Catalyzing change: Implementing standardised reporting in monogenic inflammatory bowel disease research. Journal of Pediatric Gastroenterology and Nutrition. 78(4). 759–762.
4.
Charlesworth, James, et al.. (2023). Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review. European Journal Of Haematology. 111(3). 458–476. 4 indexed citations
5.
Charlesworth, James, et al.. (2023). A case report of an unusual presentation of a patient with recurrent idiopathic catatonia. 2(1). 100111–100111. 1 indexed citations
6.
Hargreaves, Chantal E., Silvia Salatino, Sarah C. Sasson, et al.. (2021). Decreased ATM Function Causes Delayed DNA Repair and Apoptosis in Common Variable Immunodeficiency Disorders. Journal of Clinical Immunology. 41(6). 1315–1330. 8 indexed citations
7.
Charlesworth, James, et al.. (2021). Using ICD-10 diagnostic codes to identify ‘missing’ paediatric patients during nationwide COVID-19 lockdown in Oxfordshire, UK. European Journal of Pediatrics. 180(11). 3343–3357. 9 indexed citations
8.
Charlesworth, James, et al.. (2021). 1252 Neonatal SARS-CoV-2 antibodies at day 14 of life, 3.5-fold higher than her COVID-19 asymptomatic mother. Abstracts. A293.1–A293. 1 indexed citations
9.
Charlesworth, James, Shaun Wilson, Amrana Qureshi, et al.. (2021). Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children. Pediatric Blood & Cancer. 68(9). e29102–e29102. 10 indexed citations
10.
Charlesworth, James, Shelley Segal, Dominic F. Kelly, et al.. (2020). The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLH. The Lancet Rheumatology. 2(12). e736–e738. 13 indexed citations
11.
Charlesworth, James, John M. Kelley, Igho Onakpoya, et al.. (2017). Effects of placebos without deception compared with no treatment: A systematic review and meta‐analysis. Journal of Evidence-Based Medicine. 10(2). 97–107. 149 indexed citations
12.
Charlesworth, James, et al.. (2015). Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis. BMJ Open. 5(11). e009428–e009428. 8 indexed citations
13.
Achkova, Daniela, Guy W. Scadding, James Charlesworth, et al.. (2012). Interleukin-35 Suppresses Allergen-specific Th2 Response in Patients with Grass pollen induced Seasonal Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 129(2). AB208–AB208. 2 indexed citations
14.
Ross, Ewan A., Ruth E. Coughlan, Adriana Flores‐Langarica, et al.. (2011). CD31 Is Required on CD4+ T Cells To Promote T Cell Survival during Salmonella Infection. The Journal of Immunology. 187(4). 1553–1565. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026